| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 30.17B | 25.86B | 18.89B | -7.48B | 17.76B |
| Gross Profit | 30.17B | 25.86B | 2.72B | -21.25B | 2.50B |
| EBITDA | 1.39B | 0.00 | 496.30M | 49.40M | 890.10M |
| Net Income | 531.10M | 398.40M | -10.10M | 406.80M | 286.70M |
Balance Sheet | |||||
| Total Assets | 224.87B | 194.88B | 172.29B | 151.64B | 155.65B |
| Cash, Cash Equivalents and Short-Term Investments | 6.18B | 5.66B | 285.40M | 6.43B | 7.83B |
| Total Debt | 543.10M | 624.00M | 371.90M | 280.40M | 557.10M |
| Total Liabilities | 223.16B | 193.60B | 171.31B | 150.38B | 154.53B |
| Stockholders Equity | 1.48B | 1.27B | 983.40M | 1.26B | 1.12B |
Cash Flow | |||||
| Free Cash Flow | 1.07B | -664.40M | -3.50M | -1.07B | 1.41B |
| Operating Cash Flow | 1.07B | -655.70M | 18.60M | -1.05B | 1.43B |
| Investing Cash Flow | -8.40M | -17.00M | -35.20M | 232.50M | -25.10M |
| Financing Cash Flow | -535.50M | 132.30M | -209.50M | -580.50M | -231.60M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | £7.50B | 7.34 | 22.59% | 2.99% | 6.00% | -24.29% | |
76 Outperform | £8.95B | 11.95 | 12.35% | 5.37% | 4.78% | -4.86% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
67 Neutral | £538.94M | 9.42 | 10.35% | 4.39% | -7.52% | 50.23% | |
61 Neutral | £6.36B | 13.86 | 37.33% | 1.06% | -36.55% | ― | |
52 Neutral | £6.76B | 22.80 | 9.49% | 7.09% | 9.86% | -134.41% |